What You Should Know:
– Mount Sinai Tisch Cancer Center has deployed PRISM, an AI-powered platform designed by Triomics for systemwide clinical trial matching.
– Utilizing OncoLLM—a large language model pipeline built specifically for oncology—PRISM identifies…
Continue Reading
Introduction: Revolutionizing Clinical Trial Enrollment
Memorial Sloan Kettering Cancer Center (MSK), one of New York City’s leading oncology institutions, is taking a significant leap forward in cancer research by partnering with innovative startup Triomics. This…
What You Should Know:
– PathAI, a provider of AI and digital pathology solutions, and Moffitt Cancer Center, a top cancer hospital, have announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight®…
Continue Reading
Credit: Campanella, et al., Nature Medicine
What You Should Know:
– A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence…
Continue Reading
The use of Artificial Intelligence (AI) in healthcare is expanding rapidly, including in oncology. Although generic AI development and implementation frameworks exist in healthcare, no effective governance models have been reported in oncology. Our…
Continue Reading
Subspecialty knowledge barriers have limited the adoption of large language models (LLMs) in oncology. We introduce Woollie, an open-source, oncology-specific LLM trained on real-world data from Memorial Sloan Kettering Cancer Center (MSK) across lung,…
Continue Reading
Memorial Sloan Kettering Cancer Center and UnitedHealthcare are locked in a high-stakes contract negotiation that could significantly impact cancer patients across the region. The renowned cancer treatment facility has issued warnings to patients about…
Continue Reading
